|
2022-08-08
|
Ainos 宣布 330 萬美元的公開募股定價、納斯達克交易所登板和反向股票分割
|
|
2022-06-27
|
Ainos 宣布其針對 COVID-19 的低劑量口服干擾素製劑的臨床前研究取得正向積極成果
|
|
2022-06-21
|
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan
|
|
2022-05-12
|
Ainos艾諾斯新冠病毒智能抗原快速檢測試劑捐贈儀式
|
|
2021-12-07
|
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection
|
|
2021-11-03
|
Ainos SRNA Research Initiative Announces Milestones for mRNA Vaccine Development.
|
|
2021-08-16
|
Ainos Elects Ms. Hui-Lan (Celia) Wu as CFO, Lawrence K. Lin as Executive Vice President of Operations, and Other Key Executives.
|
|
2021-06-14
|
Ainos Named Exclusive Sales Partner for COVID-19 Antigen Rapid Test Kit in Taiwan.
|
|
2021-05-24
|
Ainos Announces FINRA Approval of Name Change and Ticker Symbol Change to "AIMD", Engages Firm to Explore Listing Requirements of National Securities Exchanges
|
|
2021-04-21
|
Amarillo Biosciences, Inc. Announced Closing under Securities Purchase Agreement with Majority Investor and Name Change to "Ainos, Inc."
|
